Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

First MS patients treated with Genzyme’s Lemtrada in US Genzyme has announced that the first patient with relapsing forms of multiple sclerosis (MS) has been treated with Lemtrada (alemtuzumab). Drug Research > Drug Delivery > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

FDA approves Ipsen’s Somatuline Depot Injection to treat GEP-NETs
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Ipsen Biopharmaceuticals's Somatuline Depot (lanreotide) injection 120mg to treat unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
News
New European consortium to help advance development of GSK/NIH Ebola vaccine candidate
By PBR Staff Writer
GlaxoSmithKline (GSK) and three leading research institutions have formed a new European consortium to help advance development of an Ebola vaccine candidate, which is being jointly-developed by GSK and the US National Institutes of Health (NIH).
News

Drug Discovery & Development

BioLineRx, Novartis to develop and commercialize Israeli-sourced drug candidates
By PBR Staff Writer
Clinical-stage biopharmaceutical company BioLineRx and Novartis Pharma have reached a multi-year strategic collaboration agreement to support the development and commercialization of Israeli-sourced drug candidates.
News
Novogen announces breakthrough discovery melanoma treatment
Novogen, Australian/US biotechnology company, announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
News